Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome

  • Declan P. McKernan,

    Affiliation Laboratory of Neurogastroenterology, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland

    ⨯
  • Aoife Nolan,

    Affiliation Laboratory of Neurogastroenterology, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland

    ⨯
  • Elizabeth K. Brint,

    Affiliations Laboratory of Neurogastroenterology, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland, Department of Pathology, University College Cork, Cork, Ireland

    ⨯
  • Siobhain M. O'Mahony,

    Affiliations Laboratory of Neurogastroenterology, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland, Department of Anatomy, University College Cork, Cork, Ireland

    ⨯
  • Niall P. Hyland,

    Affiliations Laboratory of Neurogastroenterology, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland, Department of Pharmacology and Therapeutics, University College Cork, Cork, Ireland

    ⨯
  • John F. Cryan ,

    j.cryan@ucc.ie (JFC); t.dinan@ucc.ie (TGD)

    Affiliations Laboratory of Neurogastroenterology, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland, School of Pharmacy, University College Cork, Cork, Ireland, Department of Pharmacology and Therapeutics, University College Cork, Cork, Ireland

    ⨯
  • Timothy G. Dinan

    j.cryan@ucc.ie (JFC); t.dinan@ucc.ie (TGD)

    Affiliations Laboratory of Neurogastroenterology, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland, Department of Psychiatry, University College Cork, Cork, Ireland

    ⨯

Abstract

Background

Irritable bowel syndrome (IBS) is largely viewed as a stress-related disorder caused by aberrant brain-gut–immune communication and altered gastrointestinal (GI) homeostasis. Accumulating evidence demonstrates that stress modulates innate immune responses; however, very little is known on the immunological effects of stress on the GI tract. Toll-like receptors (TLRs) are critical pattern recognition molecules of the innate immune system. Activation of TLRs by bacterial and viral molecules leads to activation of NF-kB and an increase in inflammatory cytokine expression. It was our hypothesis that innate immune receptor expression may be changed in the gastrointestinal tract of animals with stress-induced IBS-like symptoms.

Methodology/Principal Findings

In this study, our objective was to evaluate the TLR expression profile in the colonic mucosa of two rat strains that display colonic visceral hypersensivity; the stress-sensitive Wistar-Kyoto (WKY) rat and the maternally separated (MS) rat. Quantitative PCR of TLR2-10 mRNA in both the proximal and distal colonic mucosae was carried out in adulthood. Significant increases are seen in the mRNA levels of TLR3, 4 & 5 in both the distal and proximal colonic mucosa of MS rats compared with controls. No significant differences were noted for TLR 2, 7, 9 & 10 while TLR 6 could not be detected in any samples in both rat strains. The WKY strain have increased levels of mRNA expression of TLR3, 4, 5, 7, 8, 9 & 10 in both the distal and proximal colonic mucosa compared to the control Sprague-Dawley strain. No significant differences in expression were found for TLR2 while as before TLR6 could not be detected in all samples in both strains.

Conclusions

These data suggest that both early life stress (MS) and a genetic predisposition (WKY) to stress affect the expression of key sentinels of the innate immune system which may have direct relevance for the molecular pathophysiology of IBS.

Citation: McKernan DP, Nolan A, Brint EK, O'Mahony SM, Hyland NP, Cryan JF, et al. (2009) Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome. PLoS ONE 4(12): e8226. https://doi.org/10.1371/journal.pone.0008226

Editor: Antje Timmer, HelmholtzZentrum München, Germany

Received: June 25, 2009; Accepted: November 11, 2009; Published: December 9, 2009

Copyright: © 2009 McKernan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: The Alimentary Pharmabiotic Centre is a Centre for Science and Technology (CSET) funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan. The authors and their work were supported by SFI and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The laboratory receives funding from GlaxoSmithKline. None of the authors are employees of GlaxoSmithKline and no patents, products in development or modified products are used in these experiments. This does not alter the authors' adherence to all of the PLoS ONE policies on sharing data and materials.

Introduction

Irritable Bowel Syndrome (IBS) is a highly prevalent functional disorder of the gastrointestinal tract characterized by the presence of abdominal pain or discomfort, an alteration in bowel habit and the absence of reproducible biomarkers [1], [2]. It can result in significant impairment in quality of life and in psychological function. The precise molecular pathophysiology remains to be elucidated but altered visceral perception (visceral hypersensitivity) and gut dysmotility are important contributors to symptom progression [3], [4]. IBS is generally viewed as a disorder of the brain-gut axis with stress playing an important role [5], [6]. Moreover, accumulating evidence demonstrates that IBS patients display an over-activation of the hypothalamic-pituitary adrenal (HPA) axis which is crucial for integration of the body's response to stress [7].

Recently, we and others, have reported immune dysfunction in IBS patients [7]–[10]. Systemic inflammation is known to activate the HPA axis [11] and may account for the exaggerated HPA axis response reported in IBS such as the elevations in the inflammatory cytokine interleukin-6 (IL-6) [7]. Furthermore, it has also been shown that baseline levels of tumour necrosis factor α (TNFα), interleukin-1β (IL-1β) and IL-6 were elevated in diarrhoea predominant IBS patients (D-IBS) [10]. It is not known what causes this elevation in pro-inflammatory cytokines in the absence of visible signs of infection or inflammation; this is in contrast to post-infectious IBS (PI-IBS), where IBS symptoms develop following a gastrointestinal infection. This is thought to be due to residual inflammation post-infection and persistent changes in the colonic mucosal immune system and microbiota [12].

Toll-like receptors (TLRs) are members of the pattern recognition receptor family and play a central role in the initiation of innate cellular responses and the subsequent adaptive immune response to a variety of pathogens. There are ten TLRs in humans and they recognise different microbial ligands during infection [13]. There is also growing evidence to indicate that certain TLRs also sense products of damaged tissue [14]. Activation of the TLRs by either pathogenic ligand or host factors results in activation of downstream transcription factors such as NF-κB and IRF-3 resulting in expression of immune and inflammatory genes. TLRs are activated by various components of both bacterial and viral cell components e.g. TLR4 binds lipopolysaccharide (LPS) in gram-negative bacteria and TLR7 binds single stranded RNA (ssRNA) from viruses. Following receptor binding, a cellular protein cascade is initiated which results in the activation of NF-κB amongst other transcription factors, which in turn transcribe inflammatory cytokines [15]–[17]. TLRs are present on a variety of cell types and are found on colonic mucosal surfaces [18]. Few studies have investigated the impact of chronic stress on TLR expression and function, however of those that have done so, repeated social defeat stress has been shown to increase the expression of TLR2 and TLR4 [19] and increase TLR-mediated release of pro-inflammatory cytokines from splenic monocytes and dendritic cells [20]. Chronic restraint stress has also been shown to increase the expression of TLR4 in the spleen [21] and promotes immune suppression via PI3K signalling [22]. In this study, our objective was to examine the TLR expression profile in the colonic mucosae of two chronic stress models, the maternal separation (MS) model and Wistar-Kyoto (WKY) rats. MS rats show increased visceral hypersensitivity, increases in pro-inflammatory cytokine secretion following LPS stimulation and differences in the intestinal microbiota when compared to non separated (NS) rats [23]. Furthermore, MS rats have increased colonic permeability and increased mast cell protease release and number in the colonic mucosa [24], [25]. This mast cell activity was subsequently shown to occur in close apposition to enteric nerves [25], which is similar to that seen in IBS patients [24]. The WKY rat is a selectively bred strain that is hyper-responsive to stress [26], [27]. In particular, WKY rats have marked elevations in stress- and depression-associated changes when compared to Sprague Dawley (SD) rats, the strain most commonly used as a control comparator [28]. In addition to the depressed and anxious phenotype, increased sensitivity to colorectal distension (CRD) has been reported [23], [29], [30] coupled with alterations in colonic and gastric accommodation [31], [32] and colonic morphology [33] and function [34], [35] further supporting the use of these animals as a model relevant to IBS. Given that both MS and WKY rats are purported to have alterations in their stress and immune responses in addition to IBS-related behavioural and visceral hypersensitivity changes, we hypothesised that there could be changes in innate immune receptor expression in the gastrointestinal tract. We therefore investigated whether there were any perturbations in TLR mRNA in the colonic mucosa in both models.

Materials and Methods

Animals

Male SD and WKY rats (200–250 g,) were obtained from Harlan UK. Animals were allowed to acclimatise to our animal facility for at least one week. Temperature and light (12 hr light: 12 hr dark) were controlled, while intake of food and water were provided ad libitum. MS of facility reared SD rats was carried out from P2-P12 for 3 h per day as previously described [23]. Briefly, the MS rats were removed from their home cages at P2 and placed into plastic cages maintained at 30–33°C, in a separate room. Separations lasted for 3 h/day until P12 from 9:00 am until 12:00 pm. The NS groups were left undisturbed with their mothers.

Experimental group sizes were determined by a power calculation to detect differences at the 0.05 level. Following euthanasia by inhalable anaesthetic (isoflurane 2%) followed by decapitation; colonic mucosal scrapings (n = 5 per group) from distal and proximal colonic mucosa were collected at ∼8 weeks of age. Given that the distal and proximal colon contribute to different physiological functions the mucosae from each was analysed separately to assess if there also differed in their expression of TLRs. Specifically, the proximal colon stores food/faeces and has a major function in reabsorbing water and electrolytes whereas the distal colon has a greater role in the propulsion of the faeces out of the colon, in addition to fluid absorption [36]. Mucosal scrapings were stored in RNA Later (Ambion, Warrington, UK) at −80°C for analysis at a later date. Approval for this study was granted by University College Cork's Animal Experimentation Ethics Committee (Ethics Approval number & date).

Sample Preparation

Colonic mucosal scrapings were homogenized using a Polytron PT2100 in RNA lysis buffer until all solids were lysed (Stratagene, La Jolla, USA). RNA extraction was carried out using the Stratagene Absolutely RNA® Miniprep kit according to manufacturer's instructions. Briefly, nucleic acids were extracted using a buffer and spin column protocol. The nucleic acids were then washed and separated using an elution column. DNase treatment subsequently removed any DNA and was carried out using the Ambion Turbo DNase kit (Ambion, Warrington, UK) according to manufacturer's instructions. RNA was quantified using NanoDrop™ spectrophotometer according to the manufacturer's instructions. RNA quality was assessed using the Agilent™ Bioanalyzer (Agilent, Stockport, UK) according to the manufacturer's procedure and an RNA integrity number (RIN) was calculated. RNA with RIN value >7 was used for subsequent experiments. RNA was reverse transcribed to cDNA using the Applied Biosystems™ High Capacity cDNA kit (Applied Biosystems, Warrington, UK) according to manufacturer's instructions. Briefly, Multiscribe Reverse Transcriptase (50 U/µL) was added as part of RT master mix, incubated for 25°C for 10 mins, 37°C for 2 hrs, 85°C for 5 mins and stored at 4°C.

Quantitative Real-Time PCR

Quantitative PCR (Q-PCR) was carried out using probes (6 carboxy fluorescein - FAM) designed by Applied Biosystems™ to rat specific Toll-like receptors (TLR) 2–10 while using β-Actin as an endogenous control. Q-PCR was carried out on the ABI7300 Real Time PCR machine (Applied Biosystems, Warrington, UK). Samples were heated to 95°C for 10 mins, and then subjected to 40 cycles of amplification by melting at 95°C and annealing at 60°C for 1 min. Experimental samples were run in triplicate with 2 µL cDNA per reaction. To check for amplicon contamination, each run contained no template controls in triplicate for each probe used. Cycle threshold (Ct) values were recorded. Data was normalised using β-Actin and transformed using the 2−ΔCt method [37].

Statistical Analysis

Data are expressed as mean +/− SEM. Statistical differences were determined using Student's t-test with a correction for multiple comparisons. All tests were performed using GraphPad Prism 4 statistical software. Statistical significance was indicated as follows: * indicates p<0.05; ** indicates p<0.01 & *** indicates p<0.001.

Results

TLR Expression in Maternally Separated (MS) Compared with Non-Separated (NS) Tissues

Early life stress causes perturbations in brain gut-immune axis function [23], [38], [39]. Chronic stress has also been shown to alter TLR expression in immune cells [20], [19]. This led us to investigate if this might result in changes in the expression of TLRs in the colonic mucosa. Comparing mRNA levels, we see a significant difference in the levels of TLR3, the receptor for dsRNA [40], in the proximal (p = 0.0006) and the distal colonic mucosa (p = 0.009) (Figure 1c & 1d), TLR4 (Figure 1e & 1f), the receptor for LPS, [41] in the proximal (p = 0.0035) and the distal colonic mucosa (p<0.0001) & TLR5 (Figure 1g & 1h), the receptor for flagellin, [42] in the proximal (p = 0.0007) and the distal colonic mucosa (p<0.0001). While TLR8 was significantly increased in the proximal but not the distal colon (p = 0.0359) (Figure 2c). No significant differences were noted for TLR2, 7, 9 & 10 while TLR6 could not be detected in all samples in both rat strains.

thumbnail
Download:
Figure 1. Relative levels of Toll-like Receptor (TLR) mRNA in the distal and proximal colonic mucosa of non-separated (NS) and maternally-separated (MS) Sprague-Dawley rats.

TLR2 (a, b), TLR3 (c, d), TLR4 (e, f) & TLR5 (g, h) mRNA levels are shown in both the proximal (a, c, e & g) and the distal (b, d, f & h) colon. Data was normalized to β-Actin and expressed using the 2−ΔCt method. (** indicates p<0.01, *** indicates p<0.001).

https://doi.org/10.1371/journal.pone.0008226.g001

thumbnail
Download:
Figure 2. Relative levels of Toll-like Receptor (TLR) mRNA in the distal and proximal colonic mucosa of non-separated (NS) and maternally-separated (MS) Sprague-Dawley rats.

TLR7 (a, b), TLR8 (c, d), TLR9 (e, f) & TLR10 (g, h) mRNA levels are shown in both the proximal (a, c, e & g) and the distal (b, d, f & h) colon. Data was normalized to β-Actin and expressed using the 2−ΔCt method. (** indicates p<0.01, *** indicates p<0.001).

https://doi.org/10.1371/journal.pone.0008226.g002

TLR Expression in Wistar Kyoto (WKY) Compared with Sprague-Dawley (SD) Tissues

The WKY rat also displays visceral hypersensitivity [30] and a highly anxious phenotype [39]. In comparison to normo-anxious SD rats. WKY animals have increased mRNA expression of TLR3 in the proximal (p = 0.0072) and the distal colonic mucosa (p = 0.00477) (Figure 3 c & 3d), TLR4 in the proximal (p<0.0001) and the distal colonic mucosa (p<0.0001) (Figure 3e & 3f) and TLR5 in the proximal (p = 0.05) and the distal colonic mucosa (p<0.0001) (Figure 3g & 3h). Moreover the expression of TLR7 in the proximal (p = 0.0004) and the distal colonic mucosa (p = 0.0203) (Figure 4a & 4b), TLR8 in the proximal (p<0.0001) and the distal colonic mucosa (p<0.0001) (Figure 4c & 4d), TLR9 in the proximal (p = 0.0015) and the distal colonic mucosa (p = 0.007) (Figure 4e & 4f) and TLR10 in the proximal colonic mucosa only (p = 0.0331) (Figure 4g) was greater when compared to the SD colonic mucosa. No significant differences in expression were found for TLR2 (Figure 3a & 3b) while as before, TLR6 could not be detected in all samples in both strains. The WKY rat strain appears to show differences compared to the SD strain in the same TLRs as the MS versus NS rats but also in several other TLRs, namely TLR7, 8, 9, 10. The functional significance of this is not known at present. TLR7 is known to bind to ssRNA from viruses [43] and TLR9 is known to bind to methylated DNA from bacteria and viruses [44] while there is no known ligand for TLR10 at present. Increases in these TLRs may result in increased inflammatory cytokine production and subsequent release into the circulation [45].

thumbnail
Download:
Figure 3. Relative levels of Toll-like Receptor (TLR) mRNA in the distal and proximal colonic mucosa of Wistar-Kyoto (WKY) and Sprague-Dawley (SD) rats.

TLR2 (a, b), TLR3 (c, d), TLR4 (e, f) & TLR5 (g, h) mRNA levels are shown in both the proximal (a, c, e & g) and the distal (b, d, f & h) colon. Data was normalized to β-Actin and expressed using the 2−ΔCt method. (** indicates p<0.01, *** indicates p<0.001).

https://doi.org/10.1371/journal.pone.0008226.g003

thumbnail
Download:
Figure 4. Relative levels of Toll-like Receptor (TLR) mRNA in the distal and proximal colonic mucosa of Wistar-Kyoto (WKY) and Sprague-Dawley (SD) rats.

TLR7 (a, b), TLR8 (c, d), TLR9 (e, f) & TLR10 (g, h) mRNA levels are shown in both the proximal (a, c, e & g) and the distal (b, d, f & h) colon. Data was normalized to β-Actin and expressed using the 2−ΔCt method. (** indicates p<0.01, *** indicates p<0.001).

https://doi.org/10.1371/journal.pone.0008226.g004

Discussion

IBS is characterized by recurrent abdominal pain or discomfort at least 3 days per month for the past three months, associated with improvement of symptoms with defecation, onset associated with a change in the frequency and form/appearance of stool [46]. The syndrome has a worldwide prevalence of 10 to 15% [1], and chronic stress and anxiety have been thought to be major contributors to some of the symptoms of IBS [47]. There is an ongoing need to develop more models of irritable bowel syndrome in mice and rats to investigate the effects of chronic stress on the physiology of the gut because of the current lack of pharmacological treatments and complete understanding of the underlying causes. Two proposed rat models of IBS, the MS and WKY models used in this study have been shown to display changes in brain, gut and immune function that are relevant to the manifestation of IBS symptomatology [23], [30], [39].

At present there is a lack of reliable biomarkers in IBS patients [48]. It has been suggested that plasma cytokines maybe a putative biomarker for IBS. Pro-inflammatory cytokines such as IL-6, the IL-6 soluble receptor and IL-8 were all found to be elevated in IBS patients [7]. The increase in IL-6 and IL-8 may be linked to muscarinic receptor activity [49]. Another study has also found similar results, where IBS patients were shown to have increased levels of TNFα, IL-1β, IL6 at baseline and higher levels of LPS-induced IL-6 released in proximity or into circulation [10]. Previous work has shown that there are increased numbers of CD3+ and CD25+ in the lamina propria of IBS patients [50]. In addition, recent studies have also reported B-cell [51] and T-cell [52] activation in IBS patients suggesting aberrant immune activation. However, the origin of the cytokine release is not fully understood. One possible source of pro-inflammatory cytokine release is via activation of TLRs [45].

In this study, we have focussed on the expression of TLRs in the colonic mucosa, TLRs are key inducers of inflammation and to our knowledge, and this study shows for the first time that chronic stress in two animal models may affect the regulation of TLR expression in the colonic mucosa. In particular we demonstrate that both models display changes in the mRNA expression of TLR3, 4 and 5. As the ligands for these TLRs are both viral and bacterial this indicates that the stress models used in these experiments does not cause upregulation of any particular sub group of TLRs but results in a general increase in the level of these immune receptors. The upregulation of TLRs 4 and 5 suggests a potential increase in sensitivity to the presence of bacteria in the gut resulting in increases in cytokine production. Further studies will be needed to clarify if this is indeed the case. Interestingly, the increases seen in the WKY rat are somewhat different to the MS rats when both are compared to respective controls, indicating that these qualitatively different stressful states may differentially affect the expression of members of the innate immune receptors. Detailed comparisons between these two models may allow us to investigate further what factors may cause this differential expression. Possible reasons for these differences may lie in differences in neuroendocrine responses of the strains or the resident microbiota. We have shown that the MS model has different populations of microbiota in the gut compared to NS rats [23]. Studies analysing the microbiota in the WKY rat are ongoing. It is not known at present whether it is stress-induced changes in innate immune receptors facilitates the propagation of certain populations of bacteria or stress-induced changes in microbiota that lead to changes in innate immune receptor expression. Aside from the GI tract previous studies have shown that chronic stress may affect the expression of certain TLRs on circulating immune cells [19], [20] and our current data extend such observations to the GI colonic mucosae. It is not certain if other stress models share a similar pattern of expression as the ones mentioned in this study. We are unaware of other studies examining the immune effects of other chronic stress models in the GI tract but this is currently under investigation by our group.

It is not known at present what mechanism causes the increased expression of certain TLRs in the colonic mucosae of the MS and WKY rats. Stress, especially chronic stress is known to increase levels of glucocorticoids in addition to catecholamines, growth hormone and prolactin, all of which, have different effects on the immune system [53]. Corticosterone is elevated basally in the MS model [23] and shows a sustained increase following stress in the WKY model [54]. Glucocorticoids appear to be able to regulate the expression of certain TLRs. Of note it has been shown that glucocorticoids may synergize with either IL-1β [55], TNFα [56] or H. influenzae [57] to enhance the expression of TLR2 in human colonic or alveolar epithelial cells. A similar mechanism may exist in the stress models examined here with both showing greater stress-induced levels of glucocorticoids. Other mediators have been mentioned to affect TLR expression including catecholamines such as noradrenaline [58]. Infection with the obligate parasite T. gondii has been shown to increase expression of certain TLRs (TLR2, 4, 9 & 11 (murine)) while cold water stress following infection seems to decrease the expression of the same TLRs [58]. Noradrenaline treatment increased basal levels of certain TLRs while decreasing their expression in epithelial cells following T. gondii infection [58]. This may have relevance to IBS as catecholaminergic activity is often altered in such patients [59]. Moreover, in addition to bacterial components, fatty acids [60], [61] and opioids [62] have recently been shown to interact with TLR4 at least. These are also possibly other as yet unknown ligands that may interact with TLRs and result in the increase in cytokines seen in IBS patients

Another key question arising from this study is whether the changes in TLR expression are a state or trait marker of IBS-related symptomatology. Both these animal display visceral hypersensitivity in response to colorectal distension [23], [30]. TLRs may play an important role in visceral pain by indirectly increasing pro-inflammatory cytokine expression. It has been shown in models of neuropathic pain, where there is spinal nerve axotomy, genetic deletion of TLR2 [63], TLR3 [64] and TLR4 [65] results in reduced hypersensitivity and allodynia. More recently a TLR4 antagonist showed efficacy in a mouse peripheral nerve injury model [66]. The primary mechanism suggested in these studies is that pain results from spinal glial activation. Recently, it has been demonstrated that spinal microglia may play a key role in visceral hypersensitivity in a rat chronic stress model [67]. Inflammatory cytokine production from TLR activation may result in activation of glial cells on spinal nerves that innervate the gut.

In conclusion we have shown alterations in TLR expression levels in two models of stress which display symptoms relevant to IBS. Future studies will hopefully answer what specific chain of events causes the selective increase in TLR expression, how these are manifested at the protein level and what the functional significance of these increases are in terms of symptom manifestation in IBS. The future availability of high-quality specific antibodies targeting the various rodent TLRs would also be a major assistance in such exploits. Moreover, future investigations comparing the changes observed herein with those from other in vivo models of GI dysfunction (e.g. colitis) and/or stress are also warranted. Finally the translation of such findings into the clinical setting may pave the way for a novel biomarker of IBS where there is an immense medical need [48].

Author Contributions

Conceived and designed the experiments: EKB SMO NPH JC TD. Performed the experiments: DPM AN. Analyzed the data: DPM JC. Wrote the paper: DPM JC.

References

  1. 1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE (2002) AGA technical review on irritable bowel syndrome. Gastroenterology 123: 2108–2131.
  2. 2. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, et al. (1999) Functional bowel disorders and functional abdominal pain. Gut 45: Suppl 2II43–47.
  3. 3. Quigley EM (2003) Current concepts of the irritable bowel syndrome. Scand J Gastroenterol Suppl1–8.
  4. 4. Mayer EA, Collins SM (2002) Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 122: 2032–2048.
  5. 5. Mayer EA, Naliboff BD, Craig AD (2006) Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 131: 1925–1942.
  6. 6. Cervero F, Janig W (1992) Visceral nociceptors: a new world order? Trends Neurosci 15: 374–378.
  7. 7. Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, et al. (2006) Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130: 304–311.
  8. 8. Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, et al. (2008) Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol 43: 1467–1476.
  9. 9. Kindt S, Van Oudenhove L, Broekaert D, Kasran A, Ceuppens JL, et al. (2009) Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 21: 389–398.
  10. 10. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, et al. (2007) Immune activation in patients with irritable bowel syndrome. Gastroenterology 132: 913–920.
  11. 11. John CD, Buckingham JC (2003) Cytokines: regulation of the hypothalamo-pituitary-adrenocortical axis. Curr Opin Pharmacol 3: 78–84.
  12. 12. Spiller R, Garsed K (2009) Postinfectious irritable bowel syndrome. Gastroenterology 136: 1979–1988.
  13. 13. O'Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353–364.
  14. 14. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, et al. (2006) Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26: 430–437.
  15. 15. O'Neill LA (2008) When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29: 12–20.
  16. 16. Liew FY, Xu D, Brint EK, O'Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5: 446–458.
  17. 17. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499–511.
  18. 18. Nishimura M, Naito S (2005) Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 28: 886–892.
  19. 19. Bailey MT, Engler H, Powell ND, Padgett DA, Sheridan JF (2007) Repeated social defeat increases the bactericidal activity of splenic macrophages through a Toll-like receptor-dependent pathway. Am J Physiol Regul Integr Comp Physiol 293: R1180–1190.
  20. 20. Powell ND, Bailey MT, Mays JW, Stiner-Jones LM, Hanke ML, et al. (2009) Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion. Brain Behav Immun 23: 225–231.
  21. 21. Zhang Y, Woodruff M, Zhang Y, Miao J, Hanley G, et al. (2008) Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression. J Neuroimmunol 194: 115–122.
  22. 22. Zhang Y, Zhang Y, Miao J, Hanley G, Stuart C, et al. (2008) Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling. J Neuroimmunol 204: 13–19.
  23. 23. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, et al. (2009) Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65: 263–267.
  24. 24. Barreau F, Ferrier L, Fioramonti J, Bueno L (2004) Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats. Gut 53: 501–506.
  25. 25. Hyland NP, Julio-Pieper M, O'Mahony SM, Bulmer DC, Lee K, et al. (2009) A distinct subset of submucosal mast cells undergoes hyperplasia following neonatal maternal separation: a role in visceral hypersensitivity? Gut.
  26. 26. Lahmame A, del Arco C, Pazos A, Yritia M, Armario A (1997) Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants? Eur J Pharmacol 337: 115–123.
  27. 27. Pare WP, Redei E (1993) Depressive behavior and stress ulcer in Wistar Kyoto rats. J Physiol Paris 87: 229–238.
  28. 28. Malkesman O, Weller A (2009) Two different putative genetic animal models of childhood depression—A review. Progress in Neurobiology In Press.
  29. 29. Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA (2005) Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil 17: 415–422.
  30. 30. Gunter WD, Shepard JD, Foreman RD, Myers DA, Greenwood-Van Meerveld B (2000) Evidence for visceral hypersensitivity in high-anxiety rats. Physiol Behav 69: 379–382.
  31. 31. Martinez V, Ryttinger M, Kjerling M, Astin-Nielsen M (2007) Characterisation of colonic accommodation in Wistar Kyoto rats with impaired gastric accommodation. Naunyn Schmiedebergs Arch Pharmacol 376: 205–216.
  32. 32. Nielsen MA, Bayati A, Mattsson H (2006) Wistar Kyoto rats have impaired gastric accommodation compared to Sprague Dawley rats due to increased gastric vagal cholinergic tone. Scand J Gastroenterol 41: 773–781.
  33. 33. O'Malley D, Julio-Pieper M, Gibney SM, Dinan TG, Cryan JF (2009) Distinct aterations in clonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour Stress In Press.
  34. 34. Hyland NP, Gibney SM, Gosselin RD, Dinan TG, Cryan JF (2008) Assessment of colonic secretory function and faecal output in viscerally hypersensitive Wistar Kyoto rats. Gastroenterology 134: A552–A553.
  35. 35. Saunders PR, Santos J, Hanssen NP, Yates D, Groot JA, et al. (2002) Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig Dis Sci 47: 208–215.
  36. 36. O'Malley D, Julio-Pieper M, Gibney SM, Gosselin RD, Dinan TG, et al. (2009) Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat. Neurogastroenterol Motil. d.o.i 10.1111/j.1365-2982.2009.01412.x.
  37. 37. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.
  38. 38. Anisman H, Zaharia MD, Meaney MJ, Merali Z (1998) Do early-life events permanently alter behavioral and hormonal responses to stressors? Int J Dev Neurosci 16: 149–164.
  39. 39. Malkesman O, Braw Y, Maayan R, Weizman A, Overstreet DH, et al. (2006) Two different putative genetic animal models of childhood depression. Biol Psychiatry 59: 17–23.
  40. 40. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732–738.
  41. 41. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749–3752.
  42. 42. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, et al. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099–1103.
  43. 43. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529–1531.
  44. 44. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740–745.
  45. 45. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454: 428–435.
  46. 46. Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, et al. (2008) Functional GI disorders: from animal models to drug development. Gut 57: 384–404.
  47. 47. Arebi N, Gurmany S, Bullas D, Hobson A, Stagg A, et al. (2008) Review article: the psychoneuroimmunology of irritable bowel syndrome–an exploration of interactions between psychological, neurological and immunological observations. Aliment Pharmacol Ther 28: 830–840.
  48. 48. Clarke G, Quigley EM, Cryan JF, Dinan TG (2009) Irritable bowel syndrome: towards biomarker identification. Trends in Molecular Medicine.
  49. 49. Dinan TG, Clarke G, Quigley EM, Scott LV, Shanahan F, et al. (2008) Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol 103: 2570–2576.
  50. 50. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, et al. (2002) Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122: 1778–1783.
  51. 51. Ohman L, Lindmark AC, Isaksson S, Posserud I, Strid H, et al. (2009) B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil.
  52. 52. Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, et al. (2009) T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 104: 1205–1212.
  53. 53. Glaser R, Kiecolt-Glaser JK (2005) Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5: 243–251.
  54. 54. De La Garza R 2nd, Mahoney JJ 3rd (2004) A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression. Brain Res 1021: 209–218.
  55. 55. Sakai A, Han J, Cato AC, Akira S, Li JD (2004) Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells. BMC Mol Biol 5: 2.
  56. 56. Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA (2004) Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression. Mol Cell Biol 24: 4743–4756.
  57. 57. Shuto T, Imasato A, Jono H, Sakai A, Xu H, et al. (2002) Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 277: 17263–17270.
  58. 58. Gopal R, Birdsell D, Monroy FP (2008) Regulation of toll-like receptors in intestinal epithelial cells by stress and Toxoplasma gondii infection. Parasite Immunol 30: 563–576.
  59. 59. Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, et al. (2005) Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome. Dig Dis Sci 50: 1454–1460.
  60. 60. Milanski M, Degasperi G, Coope A, Morari J, Denis R, et al. (2009) Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 29: 359–370.
  61. 61. Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, et al. (2004) Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 279: 16971–16979.
  62. 62. Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, et al. (2009) Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun.
  63. 63. Kim D, Kim MA, Cho IH, Kim MS, Lee S, et al. (2007) A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 282: 14975–14983.
  64. 64. Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, et al. (2008) Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J Neurochem.
  65. 65. Tanga FY, Nutile-McMenemy N, DeLeo JA (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 102: 5856–5861.
  66. 66. Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, et al. (2008) Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 56: 1312–1319.
  67. 67. Bradesi S, Svensson CI, Steinauer J, Pothoulakis C, Yaksh TL, et al. (2009) Role of spinal microglia in visceral hyperalgesia and NK1R up-regulation in a rat model of chronic stress. Gastroenterology 136: 1339–1348, e1331–1332.